Life after Ozempic
Americans were told “diet and exercise” was the key to better health, but lifestyle changes were never that life changing. Medication is. This episode was produced by Miles Bryan, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Patrick Boyd and Andrea Kristinsdottir, and hosted by Noel King. Transcript at vox.com/today-explained-podcast Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members Semaglutide (GLP-1) weight-loss drug Wegovy, made by pharmaceutical company Novo Nordisk -- designed to treat type 2 diabetes, but widely known for their effect on weight loss. Photo by James Manning/PA Images via Getty Images. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Może ci się też spodobać

Siste nytt fra VG
VG

Weather Forecast from Met Éireann
Met Éireann

NPR News Now
NPR

East Coast Radio Newswatch (Bulletins)
East Coast Radio - Catch Up

Sid & Friends In The Morning
Podcast WABCRadio

Sicilia Local News
Radio Taormina

Ellinofreneia Official
Digital Minds

The Epstein Chronicles
Bobby Capucci

Internationale Presseschau
Deutschlandfunk

Wall Street Breakfast
Seeking Alpha
Dyskusja społeczności
Brak wpisów
Zacznij rozmowę o: Life after Ozempic